TriMark PublicationsTriMark Publications is a premium market-research and publishing company providing original reports in the biotechnology, medical device, diagnostic and healthcare segments. Clients benefit from an expert, objective source for their research needs, saving time and resources.TriMark Publications' reports are wide-ranging research publications that explore development activity, recent advances, and emerging trends in health care markets. In addition to our in-house proprietary database, the TriMark staff seeks out experts in the field, conducting extensive secondary research, and develops the findings into a cohesive, well-documented written analysis. Our specialty is constant staff review of reports to continually add and revise so that each report is absolutely up to date.
|
List of reports from TriMark Publications
|
Affymetrix, Inc. and Microarrays
1/1/2006 | published by: TriMark Publications
... a strategic analysis of the Affymetrix and its GeneChip microarray device: including its strengths, opportunities, weaknesses and threats. In the process, this CBASO takes a look at the functionality of the GeneChip, detailing its features, ...
|
more...
|
$300.00
|
|
Animal Health Products Antibacterials Markets
5/15/2008 | published by: TriMark Publications
... of livestock products—new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market ...
|
more...
|
$1,999.00
|
|
Annual Death Rate of U.S. Population from Heart Disease, 1950-2008
12/15/2008 | published by: TriMark Publications
... numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
more...
|
$100.00
|
|
Annual Death Rate of U.S. Population from Strokes, 1950-2008
12/15/2008 | published by: TriMark Publications
... numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
more...
|
$100.00
|
|
Anti-Infective Drugs Markets
10/1/2010 | published by: TriMark Publications
... swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world. This report TriMark Publications analyzes the anti-infective drugs market and highlights the existing and developing ...
|
more...
|
$14,200.00
|
|
Applied Biosystems Group
12/24/2006 | published by: TriMark Publications
... the technology and products for the molecular biology of Applied Biosystems, Inc. (ABI), which consists of two business units: Applera Corporation and Celera Genomics Group. The CBASO also covers: 1) polymerase chain reaction (PCR) PCR ...
|
more...
|
$300.00
|
|
Automated Microbial Testing Markets
10/1/2010 | published by: TriMark Publications
... is continual interaction between humans and microbes, ranging from disease-causing pathogenic organisms invading the human body to microorganisms harnessed by humans to aid in the fermentation of food products. The detection and characterization of these ...
|
more...
|
$1,999.00
|
|
Avian Influenza
8/16/2006 | published by: TriMark Publications
... the catastrophic health crisis avian flu poses, and the efforts by world governments and international health organizations to mitigate of the impact the threat to humans. The U.S., Asia and Europe are the focus of ...
|
more...
|
$999.00
|
|
Bioinformatics Markets
3/1/2009 | published by: TriMark Publications
... of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments ...
|
more...
|
$3,400.00
|
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
9/1/2011 | published by: TriMark Publications
... types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for early detection and screening tests for diseases such as ...
|
more...
|
$3,400.00
|
|
Blood Glucose Testing and Diabetes Management
2/1/2012 | published by: TriMark Publications
... juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the ...
|
more...
|
$3,400.00
|
|
Caffeine Levels in Energy Drinks, Carbonated Soda and Other Beverages
1/29/2009 | published by: TriMark Publications
... numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
more...
|
$100.00
|
|
Cancer Bundle
5/1/2011 | published by: TriMark Publications
... Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Below are summaries of each report. Until superior therapeutic treatments are developed ...
|
more...
|
$23,120.00
|
|
Cancer Cell Therapy Markets
3/1/2008 | published by: TriMark Publications
... the inhibition of cancer cell proliferation. In other circumstances, a variety of therapeutic molecules have been utilized lead the disease cells to perform a specific function that they normally do not. These include small molecules, ...
|
more...
|
$3,400.00
|
|
Cancer Diagnostic Testing World Markets
7/1/2011 | published by: TriMark Publications
... some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type ...
|
more...
|
$3,400.00
|
|
Cancer Therapeutics Markets
5/1/2008 | published by: TriMark Publications
... Emerging technologies include photodynamic therapy, gene therapy, biological therapy (immunotherapy) and angiogenesis inhibitors. Pharmaceutical and biotechnology companies are investing billions of dollars to search out and develop weapons for the arsenal in the war against ...
|
more...
|
$3,400.00
|
|
Cancer Vaccines Markets
5/1/2011 | published by: TriMark Publications
... of cancer immune therapy. Cancer vaccines can be divided into six main categories: antigen/adjuvant vaccines, DNA vaccines, vector-based vaccines, tumor cell vaccines, dendritic cell vaccines and anti-idiotype vaccines. This relatively new commercial market for cancer ...
|
more...
|
$3,400.00
|
|
Cardiac Marker Diagnostic Testing Markets
11/1/2011 | published by: TriMark Publications
... (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of the in vitro diagnostics (IVD) market ...
|
more...
|
$3,400.00
|
|
Cardiac Rhythm Management Devices World Markets
10/1/2011 | published by: TriMark Publications
... and ventricular arrhythmias (VA). The different types of SVA are premature atrial contractions (PAC), supraventricular tachycardia (SVT), sick sinus syndrome (SSS), atrial fibrillation (A-fib) and atrial flutter (AFL). Varying forms of VA are premature ventricular ...
|
more...
|
$3,400.00
|
|
Cell Therapy Markets
7/1/2007 | published by: TriMark Publications
... become a part of medical practice. Unlike organs, cells are a potentially renewable resource for body repair. The goal of this TriMark Publications report is to review the market for cell therapy products using screening ...
|
more...
|
$3,400.00
|
|
Cell-Based Assays for Drug Discovery
1/1/2011 | published by: TriMark Publications
... composed of those applications that require sufficient levels of sample throughput, whereby complex cellular events and phenotypes can be studied. Elements of drug performance like toxicity and specificity can be established simultaneously using mixed cell ...
|
more...
|
$3,400.00
|
|
Clinical Bundle
5/1/2011 | published by: TriMark Publications
... Clinical Laboratory Testing Volume 2: Business Strategies. Below are summaries of each report. Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining ...
|
more...
|
$10,369.00
|
|
Clinical Chemistry Analyzers
10/1/2010 | published by: TriMark Publications
... molecule in easily-collected bodily fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The analysis of virtually any biologically-active substance--any place in the body--can loosely be defined ...
|
more...
|
$3,400.00
|
|
Clinical Immunoanalyzer Markets
10/1/2010 | published by: TriMark Publications
... refers to determining the concentration or activity of protein, carbohydrate, lipid, enzyme or small molecule in easily collected body fluids, such as blood, serum, plasma or urine. However, it is not necessarily limited to these ...
|
more...
|
$3,400.00
|
|
Clinical Laboratory Testing Volume 2: Business Strategies
9/1/2010 | published by: TriMark Publications
... in connection with the diagnosis and treatment of illnesses. As such, clinical laboratory analysis is one of the most important sections of medical care. The purpose of this TriMark Publications report is to describe the ...
|
more...
|
$1,999.00
|

